Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed Aug 2, 2017 · 10-Q · 33 days after period end · 0001193125-17-245861
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | -$3.88M | -$3.64M | -$3.32M | -$3.93M |
| EPS Diluted | -$0.15 | -$0.14 | -$0.13 | -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 2, 2017 · 33 d after period end
